These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Implications of invariant residue LeuB6 in insulin-receptor interactions. Nakagawa SH; Tager HS J Biol Chem; 1991 Jun; 266(18):11502-9. PubMed ID: 2050662 [TBL] [Abstract][Full Text] [Related]
23. Crystal structure of desheptapeptide(B24-B30)insulin at 1.6 A resolution: implications for receptor binding. Bao SJ; Xie DL; Zhang JP; Chang WR; Liang DC Proc Natl Acad Sci U S A; 1997 Apr; 94(7):2975-80. PubMed ID: 9096331 [TBL] [Abstract][Full Text] [Related]
24. Perturbation of insulin-receptor interactions by intramolecular hormone cross-linking. Analysis of relative movement among residues A1, B1, and B29. Nakagawa SH; Tager HS J Biol Chem; 1989 Jan; 264(1):272-9. PubMed ID: 2642474 [TBL] [Abstract][Full Text] [Related]
25. Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor. Kurose T; Pashmforoush M; Yoshimasa Y; Carroll R; Schwartz GP; Burke GT; Katsoyannis PG; Steiner DF J Biol Chem; 1994 Nov; 269(46):29190-7. PubMed ID: 7961885 [TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of invariant valine B12 in insulin: implications for receptor binding. Nakagawa SH; Tager HS; Steiner DF Biochemistry; 2000 Dec; 39(51):15826-35. PubMed ID: 11123908 [TBL] [Abstract][Full Text] [Related]
28. [LeuB24]insulin and [AlaB24]insulin: altered structures and cellular processing of B24-substituted insulin analogs. Assoian RK; Thomas NE; Kaiser ET; Tager HS Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5147-51. PubMed ID: 6752939 [TBL] [Abstract][Full Text] [Related]
29. Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor. Xu B; Hu SQ; Chu YC; Huang K; Nakagawa SH; Whittaker J; Katsoyannis PG; Weiss MA Biochemistry; 2004 Jul; 43(26):8356-72. PubMed ID: 15222748 [TBL] [Abstract][Full Text] [Related]
30. Two mutant forms of human insulin. Structural consequences of the substitution of invariant B24- or B25-phenylalanine by leucine. Wollmer A; Strassburger W; Glatter U; Dodson GG; McCall M; Gattner HG; Danho W; Brandenburg D; Rittel W Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):581-91. PubMed ID: 7024084 [TBL] [Abstract][Full Text] [Related]
31. Importance of main-chain flexibility and the insulin fold in insulin-receptor interactions. Nakagawa SH; Tager HS Biochemistry; 1993 Jul; 32(28):7237-43. PubMed ID: 8343513 [TBL] [Abstract][Full Text] [Related]
36. Insulin analogues with modifications in the beta-turn of the B-chain. Wang SH; Hu SQ; Burke GT; Katsoyannis PG J Protein Chem; 1991 Jun; 10(3):313-24. PubMed ID: 1910463 [TBL] [Abstract][Full Text] [Related]
37. Critical role of the A2 amino acid residue in the biological activity of insulin: [2-glycine-A]- and [2-alanine-A]insulins. Kitagawa K; Ogawa H; Burke GT; Chanley JD; Katsoyannis PG Biochemistry; 1984 Mar; 23(7):1405-13. PubMed ID: 6372857 [TBL] [Abstract][Full Text] [Related]
38. [A2-Norleucine]insulin. An analog with unanticipated biological properties. Okada Y; Chanley JD; Burke GT; Katsoyannis PG Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):629-38. PubMed ID: 7024085 [TBL] [Abstract][Full Text] [Related]
39. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone. Chu YC; Zong L; Burke GT; Katsoyannis PG J Protein Chem; 1992 Oct; 11(5):571-7. PubMed ID: 1360216 [TBL] [Abstract][Full Text] [Related]
40. Enhancing the activity of a protein by stereospecific unfolding: conformational life cycle of insulin and its evolutionary origins. Hua QX; Xu B; Huang K; Hu SQ; Nakagawa S; Jia W; Wang S; Whittaker J; Katsoyannis PG; Weiss MA J Biol Chem; 2009 May; 284(21):14586-96. PubMed ID: 19321436 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]